Who are Caffree's investors?

Caffree's investors include Baruch Future Ventures, Cornucopian Capital Management.

How much funding has Caffree raised?

Caffree has disclosed $4.9M raised across 1 round.

Where is Caffree headquartered?

Caffree is headquartered in Seattle, US.

Caffree

Seattle, US · Founded 2023 · Delaware corporation · 2 known investors

Find your way into Caffree

Paths you didn't know you had: your email and LinkedIn already hold routes to the Caffree team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Caffree develops a powdered enzymatic system for precision decaffeination that converts caffeine into theobromine, allowing coffee brands to control caffeine levels without changing flavor. It targets coffee brands, cold brew and RTD beverage manufacturers, and co-packers, integrating into existing production equipment.

Biotech Deep Tech FoodTech

Founders & leadership

Eric Steven QuickExecutive

Aryeh GanzNamed on SEC filing

Board

Frank CurzioBoard director

Investors · 2

Baruch Future Ventureslisted by Baruch Future VenturesSan Francisco · $100K – $1M

Cornucopian Capital Managementlisted by Cornucopian Capital ManagementMontclair

Reported raises · per SEC filings

Form D private placements

$4.9M disclosed across 1 round · 2026

▶$4.9MraisedApr 2026 · 20 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Aryeh GanzExecutive Officer, Director, Promoter
Eric Steven QuickExecutive Officer, Director
Frank CurzioDirector

Offering amount: $7.9M
Amount sold: $4.9M
First sale: Mar 2026
Incorporated: Corporation, Delaware, 2023
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Caffree do?: Caffree develops a powdered enzymatic system for precision decaffeination that converts caffeine into theobromine, allowing coffee brands to control caffeine levels without changing flavor. It targets coffee brands, cold brew and RTD beverage manufacturers, and co-packers, integrating into existing production equipment.
Who are Caffree's investors?: Caffree's investors include Baruch Future Ventures, Cornucopian Capital Management.
How much funding has Caffree raised?: Caffree has disclosed $4.9M raised across 1 round.
Where is Caffree headquartered?: Caffree is headquartered in Seattle, US.